A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

Roche will be launching the Phase III trial to gain approval of Elevidys in Europe and other countries globally.

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...

The patient in the current case report showed manifestations of both AAV and IgG4-RD; his improvement linked to steroid/cyclophosphamide treatment underscores the need for integrated diagnosis and ...

Sarepta Therapeutics Inc.'s bid for the full Federal Circuit’s review of a revived gene-therapy patent dispute with RegenxBio ...

The firm will deliver SGT-212 to patients' brains and intravenously to try to restore frataxin levels and diminish ...

The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...

J&J will hand over the rights to bota-vec for $25 million upfront, clearing MeiraGTx to seek regulatory approvals in the U.S.

After its bet on a rare eye disease gene therapy ended in a phase 3 fail last year, Johnson & Johnson is now returning the ...